Daniel Thomas

Trump Media plans a complex deal to spin off Truth Social after its fusion energy merger, aiming to create two distinct publicly traded companies.

Following a stellar earnings report, the ad tech firm heads to key conferences to pitch its AI and privacy-first strategy in a post-cookie world.

Amid rising scrutiny and a new integrity code, a landmark certification course aims to professionalize Hong Kong's sports bodies from the inside out.

A market void left by two US titans creates a massive opportunity for a French brand specializing in realistic, plant-based temporary tattoos.

A critical vulnerability in the OpenClaw AI agent allowed any website to silently hijack developer tools, exposing a new and dangerous class of security risks.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

Energy firm Prevalon and crypto bank Anchorage Digital add Strategy's high-yield STRC to their treasuries, marking a key step for institutional adoption.

A new DeFi service lets you pay bills by borrowing against your crypto portfolio without selling, but does this financial freedom come with hidden risks?

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

New research shows assessment fraud more than doubled in 2025, driven by AI and hitting entry-level roles hardest. How can companies ensure fair hiring?

The cold storage giant saw strong cash flow growth in 2025 despite a net loss, but its conservative 2026 forecast signals persistent industry headwinds.

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Cutting Horse, led by operators behind billion-dollar brands, exceeds its target to deploy capital and hands-on expertise to founder-led businesses.

Amidst industry-wide regulatory challenges, Meridian secures critical IVDR certification for its Alethia assays, ensuring continued market access in Europe.

A new platform, Venn.ai, promises to let AI take real action in business apps, but with a critical feature: a human-in-the-loop safety switch.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

Tired of juggling multiple health portals? Pixel Health's new AI-powered platform, One Thread, aims to unify the patient journey into a single experience.

A new state-backed decal helps consumers spot legal cannabis sellers. Discover how the 'Verified Dispensary' program aims to ensure safety and combat illicit sales.

Arrotex secures rights to an innovative, FDA-approved nanotech eye drop, promising faster, simpler recovery for thousands of surgical patients.

New York's 2026 housing market opens with a puzzle: sales are down 7.5%, yet the median home price soars to $445,000. Who can still afford to buy?